Author:
Hayes Karen E.,Batsomboon Paratchata,Chen Wei-Chih,Johnson Brennan D.,Becker Andreas,Eschrich Steven,Yang Yan,Robart Aaron R.,Dudley Gregory B.,Geldenhuys Werner J.,Hazlehurst Lori A.
Funder
NIH
WVU
National Institute of General Medical Sciences
Core
Moffitt Cancer Center
Comprehensive Cancer Center
Subject
Organic Chemistry,Clinical Biochemistry,Drug Discovery,Pharmaceutical Science,Molecular Biology,Molecular Medicine,Biochemistry
Reference21 articles.
1. Multiple myeloma: new insights and therapeutic approaches, hematology;Anderson;Am Soc Hematol Educ Program,2000
2. The proteasome inhibitor PS-341 inhibits growth, induces apoptosis, and overcomes drug resistance in human multiple myeloma cells;Hideshima;Cancer Res,2001
3. Potent activity of carfilzomib, a novel, irreversible inhibitor of the ubiquitin-proteasome pathway, against preclinical models of multiple myeloma;Kuhn;Blood,2007
4. The proteasome and proteasome inhibitors in multiple myeloma;Gandolfi;Cancer Metastasis Rev,2017
5. Resistance to proteasome inhibitors and other targeted therapies in myeloma;Wallington-Beddoe;Br J Haematol,2018
Cited by
27 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献